The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 trial of Symptom screening with Targeted Early Palliative care (STEP) for patients with advanced cancer.
 
Camilla Zimmermann
No Relationships to Disclose
 
Breffni Hannon
No Relationships to Disclose
 
Monika K. Krzyzanowska
Honoraria - Eisai; Novartis
Consulting or Advisory Role - Eisai
Research Funding - Eisai (Inst); Exelixis (Inst); Ipsen (Inst)
 
Madeline Li
No Relationships to Disclose
 
Gary Rodin
No Relationships to Disclose
 
Ashley Pope
No Relationships to Disclose
 
Nadia Swami
No Relationships to Disclose
 
Mohana Giruparajah
No Relationships to Disclose
 
Doris Howell
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
David Warr
Consulting or Advisory Role - Helsinn Healthcare; Merck
Speakers' Bureau - Merck
Research Funding - Merck
 
Jennifer J. Knox
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Merck
Research Funding - AstraZeneca; Merck
 
Natasha B. Leighl
Research Funding - Novartis (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Nektar; Pfizer; Roche; Roche/Genentech
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Sanofi (Inst)
 
Rebecca M. Prince
No Relationships to Disclose
 
Stephanie Lheureux
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - AstraZeneca (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Aaron Richard Hansen
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline/Novartis; Merck; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Christopher M. Booth
No Relationships to Disclose
 
Deborah Jane Dudgeon
No Relationships to Disclose
 
Lisa W Le
No Relationships to Disclose